Patents-Review.com
ClassID:

114178 ⎘

C12Y113/11052 - CPC Classification

Classification description:

Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11) Indoleamine 2,3-dioxygenase (1.13.11.52), i.e. indoleamine 2,3-dioxygenase 1

Recent Application in this class:
#1
20250333702
2025-10-30

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #2
20250327041
2025-10-23

NUCLEOTIDE DELIVERY OF CANCER THERAPY

 #3
20250319159
2025-10-16

INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY

 #4
20250101381
2025-03-27

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #5
20240401006
2024-12-05

MRNAS ENCODING CHIMERIC METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF

 #6
20240350669
2024-10-24

INHIBITION OF KYNURENINE SYNTHESIS AND/OR SIGNALING TO TREAT LEUKEMIA AND MYELODYSPLASIA

 #7
20240307516
2024-09-19

COMBINATION THERAPY FOR CANCER

 #8
20240245730
2024-07-25

SYNTHETIC PROTEIN FOR INDUCING IMMUNE TOLERANCE

 #9
20240238384
2024-07-18

Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) Agonists

 #10
20240100051
2024-03-28

Anti-Tumor Immunotherapy Enhancer

 #11
20230390365
2023-12-07

GENE THERAPEUTICS FOR ENHANCEMENT/RESTORATION OF ENDOMETRIAL FUNCTION

 #12
20230365677
2023-11-16

CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY

 #13
20230233657
2023-07-27

Indoleamine 2,3-dioxygenase based immunotherapy

 #14
20230210899
2023-07-06

CAR-Treg-Based Therapies Targeting Myelin Oligodendrocyte Glycoprotein (MOG) for Treating Neurodegenerative Diseases

 #15
20230026716
2023-01-26

Checkpoint blockade and microsatellite instability

 #16
20230002733
2023-01-05

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #17
20220275086
2022-09-01

Checkpoint blockade and microsatellite instability

 #18
20220267948
2022-08-25

PROCESS FOR DYEING TEXTILES

 #19
20220259312
2022-08-18

Checkpoint blockade and microsatellite instability

 #20
20220249641
2022-08-11

Indoleamine 2,3-dioxygenase based immunotherapy

 #21
20220229066
2022-07-21

Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1)

 #22
20220202922
2022-06-30

INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY

 #23
20220056129
2022-02-24

Checkpoint blockade and microsatellite instability

 #24
20210395365
2021-12-23

Checkpoint blockade and microsatellite instability

 #25
20210324078
2021-10-21

Checkpoint blockade and microsatellite instability

 #26
20210324077
2021-10-21

Checkpoint blockade and microsatellite instability

 #27
20210155693
2021-05-27

Checkpoint blockade and microsatellite instability

 #28
20210130463
2021-05-06

Checkpoint blockade and microsatellite instability

 #29
20210107978
2021-04-15

Checkpoint blockade and microsatellite instability

 #30
20210002371
2021-01-07

COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND IDO1 INHIBITOR FOR THE TREATMENT OF CANCER

 #31
20200383981
2020-12-10

Anti-tumor immunotherapy enhancer

 #32
20200371101
2020-11-26

Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)

 #33
20200338110
2020-10-29

Reducing beta-catenin and IDO expression to potentiate immunotherapy

 #34
20200172870
2020-06-04

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #35
20200157549
2020-05-21

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy

 #36
20200102540
2020-04-02

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #37
20190376973
2019-12-12

Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof

 #38
20190218264
2019-07-18

Targeted effector proteins and uses thereof

 #39
20190201512
2019-07-04

Indoleamine 2,3-dioxygenase based immunotherapy

 #40
20190153452
2019-05-23

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy

 #41
20190023787
2019-01-24

Checkpoint blockade and microsatellite instability

 #42
20180112180
2018-04-26

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #43
20180099057
2018-04-12

Nanoplatforms for arginase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase detection by posttranslational modification

 #44
20170313775
2017-11-02

Checkpoint Blockade and Microsatellite Instability

 #45
20170146535
2017-05-25

Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof

 #46
20170081671
2017-03-23

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy

 #47
20170049868
2017-02-23

Indoleamine 2,3-dioxygenase based immunotherapy

 #48
20160299146
2016-10-13

Kynurenine Pathway Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response

 #49
20150343037
2015-12-03

Treatment of bone diseases

 #50
20140186401
2014-07-03

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy

 #51
20110318372
2011-12-29

Indoleamine 2,3-dioxygenase based immunotherapy

 #52
20110307076
2011-12-15

Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #53
20110196023
2011-08-11

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #54
20110196022
2011-08-11

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #55
20100249221
2010-09-30

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #56
20100247487
2010-09-30

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #57
20090238795
2009-09-24

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors